NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,746,465 | +9.7% | 136,225 | 0.0% | 0.54% | +12.8% |
| Q1 2023 | $12,532,700 | +1.4% | 136,225 | 0.0% | 0.48% | +2.1% |
| Q4 2022 | $12,358,332 | +19.4% | 136,225 | 0.0% | 0.47% | +10.1% |
| Q3 2022 | $10,354,000 | -10.1% | 136,225 | 0.0% | 0.42% | -6.4% |
| Q2 2022 | $11,515,000 | -3.7% | 136,225 | 0.0% | 0.45% | +7.9% |
| Q1 2022 | $11,954,000 | +0.3% | 136,225 | 0.0% | 0.42% | +9.7% |
| Q4 2021 | $11,916,000 | +7.0% | 136,225 | 0.0% | 0.38% | +6.7% |
| Q3 2021 | $11,140,000 | -10.4% | 136,225 | 0.0% | 0.36% | -11.1% |
| Q2 2021 | $12,429,000 | +6.7% | 136,225 | 0.0% | 0.40% | +0.7% |
| Q1 2021 | $11,645,000 | -14.7% | 136,225 | -5.7% | 0.40% | -16.5% |
| Q4 2020 | $13,647,000 | +3.6% | 144,525 | -4.6% | 0.48% | -2.8% |
| Q3 2020 | $13,177,000 | -11.8% | 151,525 | -11.4% | 0.49% | -13.0% |
| Q2 2020 | $14,936,000 | +0.7% | 171,008 | -4.9% | 0.57% | -15.2% |
| Q1 2020 | $14,828,000 | -25.8% | 179,847 | -14.8% | 0.67% | -11.4% |
| Q4 2019 | $19,984,000 | -7.8% | 211,047 | -15.4% | 0.76% | -20.1% |
| Q3 2019 | $21,677,000 | -14.3% | 249,447 | -10.0% | 0.95% | -8.3% |
| Q2 2019 | $25,297,000 | -5.0% | 277,047 | +0.1% | 1.03% | -4.5% |
| Q1 2019 | $26,616,000 | +6.3% | 276,847 | -5.1% | 1.08% | +0.9% |
| Q4 2018 | $25,032,000 | -10.0% | 291,717 | -9.6% | 1.07% | +6.2% |
| Q3 2018 | $27,803,000 | +24.4% | 322,690 | +9.1% | 1.01% | +18.9% |
| Q2 2018 | $22,346,000 | -21.3% | 295,820 | -15.7% | 0.85% | -23.2% |
| Q1 2018 | $28,380,000 | -11.5% | 351,020 | -8.1% | 1.10% | -10.8% |
| Q4 2017 | $32,063,000 | -6.3% | 381,882 | -4.2% | 1.24% | +1.1% |
| Q3 2017 | $34,225,000 | +2.9% | 398,662 | 0.0% | 1.22% | -0.8% |
| Q2 2017 | $33,276,000 | +80.1% | 398,662 | +60.2% | 1.23% | +72.2% |
| Q1 2017 | $18,478,000 | +2.0% | 248,800 | 0.0% | 0.72% | -7.3% |
| Q4 2016 | $18,123,000 | -7.7% | 248,800 | 0.0% | 0.77% | +2.3% |
| Q3 2016 | $19,645,000 | +40.0% | 248,800 | +46.3% | 0.76% | +31.8% |
| Q2 2016 | $14,035,000 | +109.0% | 170,100 | +83.5% | 0.57% | +100.3% |
| Q1 2016 | $6,715,000 | -15.8% | 92,700 | 0.0% | 0.29% | -1.0% |
| Q4 2015 | $7,976,000 | -6.4% | 92,700 | 0.0% | 0.29% | -5.6% |
| Q3 2015 | $8,521,000 | – | 92,700 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |